QuidelOrtho Corp (QDEL) stock
QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.57−0.30 (-3.04%)
Close on Nov 18, 2026Market cap $656.27MP/E –Yield –
QuidelOrtho price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
QuidelOrtho's price to book ratio was 0.5× on Nov 11, 2026, against 0.9× a year earlier. Over the last 5 years it ranged from 0.4× to 4.4×, with a median of 0.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.5× | −0.5 |
| 2025 | Dec 31, 2025 | 1.0× | +0.0 |
| 2024 | Dec 31, 2024 | 0.9× | −0.1 |
| 2023 | Dec 29, 2023 | 1.0× | −0.2 |
| 2022 | Dec 30, 2022 | 1.2× | −3.2 |
| 2021 | Dec 31, 2021 | 4.4× | – |
See a number that looks wrong?